New Secondary Antibodies Launched for Camelid Antibody Development

David Fancy, Ph.D., Chief Operations Officer for Jackson Immuno Research announces the launch of new anti-camelid antibodies that are not just for the development of nanobodies from alpaca and llamas, but can also be used in downstream applications.